Asker Healthcare Group AB's EBIT per Share for the
three
months ended in Mar. 2026 was kr1.06.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was kr3.23.
During the past 12 months, the average EBIT per Share Growth Rate of Asker Healthcare Group AB was 2.70% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 11.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Asker Healthcare Group AB's EBIT per Share or its related term are showing as below:
OSTO:ASKER'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 11.1 Med: 11.1 Max: 11.1
Current: 11.1
During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of Asker Healthcare Group AB was 11.10% per year. The lowest was 11.10% per year. And the median was 11.10% per year.
OSTO:ASKER's 3-Year EBIT Growth Rate is ranked better than 66.67% of 105
companies
in the Medical Distribution industry
Industry Median: 4.2
vs OSTO:ASKER: 11.10
Asker Healthcare Group AB (OSTO:ASKER) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Asker Healthcare Group AB EBIT per Share Related Terms
Asker Healthcare Group AB EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr3.23
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asker Healthcare Group AB (OSTO:ASKER) has a EBIT per Share of kr3.23 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Asker Healthcare Group AB and its competitors. According to the industry distribution chart, Asker Healthcare Group AB ranks #35 out of 105 companies in the Medical Distribution industry, placing it in the top 33.3%.
Is Asker Healthcare Group AB's EBIT per Share too high?
Asker Healthcare Group AB's current EBIT per Share is kr3.23. Based on the distribution chart, Asker Healthcare Group AB ranks #35 out of 105 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Asker Healthcare Group AB has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Asker Healthcare Group AB's EBIT per Share compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Asker Healthcare Group AB ranks #35 out of 105 companies for EBIT per Share. This puts Asker Healthcare Group AB in the upper half of its industry. The industry median EBIT per Share is 4.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Distribution company?
The median EBIT per Share among Medical Distribution companies is 4.20, based on 105 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Asker Healthcare Group AB and its competitors. For the Medical Distribution industry, the median EBIT per Share is 4.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asker Healthcare Group AB's current EBIT per Share is kr3.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asker Healthcare Group AB stock overvalued right now?
Asker Healthcare Group AB (OSTO:ASKER) has a current EBIT per Share of kr3.23. The current EBIT per Share is kr3.23. Asker Healthcare Group AB's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Asker Healthcare Group AB (OSTO:ASKER), the current EBIT per Share is kr3.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability. Company has adapted a twin engine growth strategy that combines organic and acquired growth. Geographically, the company evaluates the operations in three business areas: North, West and Central.
13GF Score
Get the complete analysis for OSTO:ASKER
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ASKER has been successfully added to your 
